These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15155543)

  • 21. IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71).
    Bottazzo GF; Bosi E; Cull CA; Bonifacio E; Locatelli M; Zimmet P; Mackay IR; Holman RR
    Diabetologia; 2005 Apr; 48(4):703-8. PubMed ID: 15765222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tyrosine phosphatase-like protein (IA-2) and glutamic acid decarboxylase (GAD65) autoantibodies: a study of Chinese patients with diabetes mellitus.
    Ng WY; Lee YS; Todd AL; Lui KF; Loke KY; Thai AC
    Autoimmunity; 2002 Mar; 35(2):119-24. PubMed ID: 12073931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children.
    Savola K; Sabbah E; Kulmala P; Vähäsalo P; Ilonen J; Knip M
    Diabetologia; 1998 Nov; 41(11):1293-7. PubMed ID: 9833935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study.
    Davis TM; Zimmet P; Davis WA; Bruce DG; Fida S; Mackay IR
    Diabet Med; 2000 Sep; 17(9):667-74. PubMed ID: 11051287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of Antibodies Directed to the N-Terminal Region of GAD Is Dependent on Assay Format and Contributes to Differences in the Specificity of GAD Autoantibody Assays for Type 1 Diabetes.
    Williams AJ; Lampasona V; Schlosser M; Mueller PW; Pittman DL; Winter WE; Akolkar B; Wyatt R; Brigatti C; Krause S; Achenbach P;
    Diabetes; 2015 Sep; 64(9):3239-46. PubMed ID: 25972570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein tyrosine phosphatase-like protein IA2-antibodies plus glutamic acid decarboxylase 65 antibodies (GADA) indicates autoimmunity as frequently as islet cell antibodies assay in children with recently diagnosed diabetes mellitus.
    Borg H; Fernlund P; Sundkvist G
    Clin Chem; 1997 Dec; 43(12):2358-63. PubMed ID: 9439455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A simple screening method for individuals at risk of developing type 1 diabetes: measurement of islet cell autoantibodies (GADA, IA-2A, and IAA) on dried capillary blood spots collected on filter paper.
    Siraj ES; Rogers DG; Gupta MK; Reddy SS
    Horm Metab Res; 2012 Oct; 44(11):855-60. PubMed ID: 22893260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Change of glutamic acid decarboxylase antibody and protein tyrosine phosphatase antibody in Chinese patients with acute-onset type 1 diabetes mellitus.
    Chao C; Huang G; Li X; Yang L; Lin J; Jin P; Luo SM; Zhang YY; Pan LL; Zhou ZG
    Chin Med J (Engl); 2013 Nov; 126(21):4006-12. PubMed ID: 24229665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
    Reinsch B; Zimmy S; Schatz H; Pfohl M
    Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary risk factors for the emergence of type 1 diabetes-related autoantibodies in 21/2 year-old Swedish children.
    Wahlberg J; Vaarala O; Ludvigsson J;
    Br J Nutr; 2006 Mar; 95(3):603-8. PubMed ID: 16578935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group.
    Kulmala P; Savola K; Petersen JS; Vähäsalo P; Karjalainen J; Löppönen T; Dyrberg T; Akerblom HK; Knip M
    J Clin Invest; 1998 Jan; 101(2):327-36. PubMed ID: 9435304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2.
    Törn C; Mueller PW; Schlosser M; Bonifacio E; Bingley PJ;
    Diabetologia; 2008 May; 51(5):846-52. PubMed ID: 18373080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DELISA: sensitive nonisotopic assay for GAD65 autoantibodies, a key risk-assessment marker for insulin-dependent diabetes mellitus.
    Mehta HB; Vold BS; Minkin S; Ullman EF
    Clin Chem; 1996 Feb; 42(2):263-9. PubMed ID: 8595722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoantibodies predicting diabetes mellitus type I in celiac disease.
    Galli-Tsinopoulou A; Nousia-Arvanitakis S; Dracoulacos D; Xefteri M; Karamouzis M
    Horm Res; 1999; 52(3):119-24. PubMed ID: 10725775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiplex agglutination-PCR (ADAP) autoantibody assays compared to radiobinding autoantibodies in type 1 diabetes and celiac disease.
    Lind A; de Jesus Cortez F; Ramelius A; Bennet R; Robinson PV; Seftel D; Gebhart D; Tandel D; Maziarz M; Agardh D; Larsson HE; Lundgren M; Tsai CT; Lernmark Å
    J Immunol Methods; 2022 Jul; 506():113265. PubMed ID: 35358496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3 Screen islet cell autoantibody ELISA: A sensitive and specific ELISA for the combined measurement of autoantibodies to GAD
    Amoroso M; Achenbach P; Powell M; Coles R; Chlebowska M; Carr L; Furmaniak J; Scholz M; Bonifacio E; Ziegler AG; Rees Smith B
    Clin Chim Acta; 2016 Nov; 462():60-64. PubMed ID: 27570064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection and immunochemical characterization of glutamic acid decarboxylase autoantibodies in patients with autoimmune diabetes mellitus.
    Villalba A; Iacono RF; Valdez SN; Poskus E
    Autoimmunity; 2008 Mar; 41(2):143-53. PubMed ID: 18324484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnostic value of protein tyrosine phosphatase-2beta antibody (IA-2betaA) in type 1 diabetes].
    Li H; Huang G; Zhang S; Wang X; Jin HL; Zhou ZG
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):939-42. PubMed ID: 18756962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of 2 alternative enzyme-linked immunosorbent assays for routine screening of glutamic acid decarboxylase autoantibodies.
    Villalba A; Valdez SN; Iacono RF; Poskus E
    Clin Chim Acta; 2007 Feb; 376(1-2):82-7. PubMed ID: 16963012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.